Rhino-orbital mucormycosis

Byoung U. Ryu, Noor Adnan Rashid Laylani, Pamela Davila-Siliezar, Andrew G. Lee

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Purpose of reviewThe current article will update and review the clinical and radiological manifestations and management of rhino-orbital mucormycosis (ROM).Recent findingsThere has been an increase in cases of ROM worldwide, especially in India. Immunosuppression (especially diabetes mellitus) is a known predisposing risk factor for ROM. Delayed diagnosis and treatment of ROM can be vision or life-threatening. This article reviews the clinical and radiologic features, treatment, and prognosis of ROM with special emphasis on new and emerging therapies.SummaryROM is an angioinvasive fungal infection that affects the sinuses and orbits and may present to ophthalmologists. Clinicians should have a high index of suspicion for ROM, especially in patients with poorly controlled diabetes mellitus or other immunosuppression. Corticosteroid treatment (including the recent COVID-19 pandemic) may be a predisposing risk factor for ROM.

Original languageEnglish (US)
Pages (from-to)501-506
Number of pages6
JournalCurrent Opinion in Ophthalmology
Issue number6
StatePublished - Nov 1 2022


  • COVID-19-associated mucormycosis
  • orbital exenteration
  • orbital mucormycosis
  • rhino-orbital mucormycosis

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Rhino-orbital mucormycosis'. Together they form a unique fingerprint.

Cite this